Literature DB >> 9703328

Cloning of the promoters for the beta-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1.

R Ashfield1, S J Ashcroft.   

Abstract

The beta-cell ATP-sensitive potassium channel (K-ATP channel), which regulates insulin secretion, is composed of two types of subunits: 1) a sulfonylurea receptor (SUR1) and 2) an inwardly rectifying potassium channel (Kir6.2). We have isolated clones containing 5'-flanking DNA for both genes by hybridization screening of a human genomic library. Sequencing of over one kilobase of each upstream region has revealed that the putative promoters are G + C rich, with no TATA box. Several E-boxes and potential Sp1 sites are present in both promoters, and the Kir6.2 upstream region contains an Alu repeat. Using a luciferase reporter gene in transient transfection assays, we demonstrate that the upstream DNA contains promoters that are active in the beta-cell lines HIT T15 and MIN6. The promoters are completely inactive in the fibroblast cell line COS7 but show some activity in HepG2 (liver) and HEK293 (epithelial) cell lines. Deletion analysis suggests that a short (173-base pair [bp]) fragment of SUR1 5'-flanking sequence is sufficient for maximal promoter activity. In contrast, over 900 bp of Kir6.2 5' sequence are required for similar high level expression, and deletion of the Alu repeat results in an increase in promoter activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703328     DOI: 10.2337/diab.47.8.1274

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action.

Authors:  Diethart Schmid; Michael Stolzlechner; Albin Sorgner; Caterina Bentele; Alice Assinger; Peter Chiba; Thomas Moeslinger
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

Review 2.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

3.  Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.

Authors:  Seung Kyoon Woo; Min Seong Kwon; Zhihua Geng; Zheng Chen; Alexander Ivanov; Sergei Bhatta; Volodymyr Gerzanich; J Marc Simard
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

Review 4.  Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

Authors:  J Marc Simard; Thomas A Kent; Mingkui Chen; Kirill V Tarasov; Volodymyr Gerzanich
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

Review 5.  Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review.

Authors:  Ruchira M Jha; Anupama Rani; Shashvat M Desai; Sudhanshu Raikwar; Sandra Mihaljevic; Amanda Munoz-Casabella; Patrick M Kochanek; Joshua Catapano; Ethan Winkler; Giuseppe Citerio; J Claude Hemphill; W Taylor Kimberly; Raj Narayan; Juan Sahuquillo; Kevin N Sheth; J Marc Simard
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

6.  Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.

Authors:  J Marc Simard; Natalia Tsymbalyuk; Orest Tsymbalyuk; Svetlana Ivanova; Vladimir Yurovsky; Volodymyr Gerzanich
Journal:  Stroke       Date:  2010-01-21       Impact factor: 7.914

7.  Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

Authors:  J Marc Simard; Mingkui Chen; Kirill V Tarasov; Sergei Bhatta; Svetlana Ivanova; Ludmila Melnitchenko; Natalya Tsymbalyuk; G Alexander West; Volodymyr Gerzanich
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

Review 8.  Sulfonylurea receptor 1 in central nervous system injury: a focused review.

Authors:  J Marc Simard; S Kyoon Woo; Gary T Schwartzbauer; Volodymyr Gerzanich
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-20       Impact factor: 6.200

9.  Relative expression of a dominant mutated ABCC8 allele determines the clinical manifestation of congenital hyperinsulinism.

Authors:  Ruth Shemer; Carmit Avnon Ziv; Efrat Laiba; Qing Zhou; Joel Gay; Sharona Tunovsky-Babaey; Show-Ling Shyng; Benjamin Glaser; David H Zangen
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

10.  Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes.

Authors:  Naheed Fatima; James F Schooley; Willliam C Claycomb; Thomas P Flagg
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.